Systematic screening of generic drugs for progressive multiple sclerosis identifies clomipramine as a promising therapeutic
Progressive multiple sclerosis is an inflammatory and degenerative disease of the central nervous system, for which effective treatment is lacking. The authors carry out a screen to identify orally available generic medications, and show that the antidepressant clomipramine reduces pathology in mous...
Main Authors: | Simon Faissner, Manoj Mishra, Deepak K. Kaushik, Jianxiong Wang, Yan Fan, Claudia Silva, Gail Rauw, Luanne Metz, Marcus Koch, V. Wee Yong |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2017-12-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-017-02119-6 |
Similar Items
-
Clomipramine, clomiphene, and generic drug-dispensing errors
by: Amar Bavle, et al.
Published: (2016-01-01) -
Clomipramine for Compulsive Tics
by: J Gordon Millichap
Published: (1994-08-01) -
Rhabdomyolysis as a manifestation of clomipramine poisoning
by: Nathalie Oliveira de Santana, et al. -
Expanding the Potential Therapeutic Options for Remote Ischemic Preconditioning: Use in Multiple Sclerosis
by: Carlos R. Camara-Lemarroy, et al.
Published: (2018-06-01) -
Clomipramine and fluoxetine effects in the treatment of panic disorder
by: Semra Čavaljuga, et al.
Published: (2003-08-01)